These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27505005)

  • 1. Vaccine Potential and Diversity of the Putative Cell Binding Factor (CBF, NMB0345/NEIS1825) Protein of Neisseria meningitidis.
    Humbert MV; Hung MC; Phillips R; Akoto C; Hill A; Tan WM; Heckels JE; Christodoulides M
    PLoS One; 2016; 11(8):e0160403. PubMed ID: 27505005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A putative amino acid ABC transporter substrate-binding protein, NMB1612, from Neisseria meningitidis, induces murine bactericidal antibodies against meningococci expressing heterologous NMB1612 proteins.
    Hung MC; Humbert MV; Laver JR; Phillips R; Heckels JE; Christodoulides M
    Vaccine; 2015 Aug; 33(36):4486-94. PubMed ID: 26207592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with recombinant Chaperonin60 (Chp60) outer membrane protein induces a bactericidal antibody response against Neisseria meningitidis.
    Phillips R; Williams JN; Tan WM; Bielecka MK; Thompson H; Hung MC; Heckels JE; Christodoulides M
    Vaccine; 2013 May; 31(22):2584-90. PubMed ID: 23566947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with recombinant truncated Neisseria meningitidis-Macrophage Infectivity Potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for Neisseria gonorrhoeae.
    Humbert MV; Christodoulides M
    Vaccine; 2018 Jun; 36(27):3926-3936. PubMed ID: 29803329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adhesin complex protein (ACP) of Neisseria meningitidis is a new adhesin with vaccine potential.
    Hung MC; Heckels JE; Christodoulides M
    mBio; 2013 Feb; 4(2):. PubMed ID: 23443003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Neisseria meningitidis macrophage infectivity potentiator protein induces cross-strain serum bactericidal activity and is a potential serogroup B vaccine candidate.
    Hung MC; Salim O; Williams JN; Heckels JE; Christodoulides M
    Infect Immun; 2011 Sep; 79(9):3784-91. PubMed ID: 21708989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci.
    Jolley KA; Appleby L; Wright JC; Christodoulides M; Heckels JE
    Infect Immun; 2001 Jun; 69(6):3809-16. PubMed ID: 11349046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with the recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis.
    Wright JC; Williams JN; Christodoulides M; Heckels JE
    Infect Immun; 2002 Aug; 70(8):4028-34. PubMed ID: 12117908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1.
    Marini A; Rossi O; Aruta MG; Micoli F; Rondini S; Guadagnuolo S; Delany I; Henderson IR; Cunningham AF; Saul A; MacLennan CA; Koeberling O
    PLoS One; 2017; 12(7):e0181508. PubMed ID: 28742866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant protein truncation strategy for inducing bactericidal antibodies to the macrophage infectivity potentiator protein of Neisseria meningitidis and circumventing potential cross-reactivity with human FK506-binding proteins.
    Bielecka MK; Devos N; Gilbert M; Hung MC; Weynants V; Heckels JE; Christodoulides M
    Infect Immun; 2015 Feb; 83(2):730-42. PubMed ID: 25452551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of the Recombinant
    Almonacid-Mendoza HL; Humbert MV; Dijokaite A; Cleary DW; Soo Y; Hung MC; Orr CM; Machelett MM; Tews I; Christodoulides M
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30305317
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of vaccine potential of the Neisseria-specific protein NMB0938.
    Sardiñas G; Climent Y; Rodríguez Y; González S; García D; Cobas K; Caballero E; Pérez Y; Brookes C; Taylor S; Gorringe A; Delgado M; Pajón R; Yero D
    Vaccine; 2009 Nov; 27(49):6910-7. PubMed ID: 19751688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strains.
    Moe GR; Zuno-Mitchell P; Hammond SN; Granoff DM
    Infect Immun; 2002 Nov; 70(11):6021-31. PubMed ID: 12379678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the immunogenicity of a trivalent Neisseria meningitidis native outer membrane vesicle vaccine by genetic modification.
    Zhang L; Wen Z; Lin J; Xu H; Herbert P; Wang XM; Mehl JT; Ahl PL; Dieter L; Russell R; Kosinski MJ; Przysiecki CT
    Vaccine; 2016 Jul; 34(35):4250-4256. PubMed ID: 27269057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development.
    Pajon R; Fergus AM; Koeberling O; Caugant DA; Granoff DM
    PLoS Negl Trop Dis; 2011 Sep; 5(9):e1302. PubMed ID: 21909444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity.
    Welsch JA; Moe GR; Rossi R; Adu-Bobie J; Rappuoli R; Granoff DM
    J Infect Dis; 2003 Dec; 188(11):1730-40. PubMed ID: 14639545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The meningococcal transferrin-binding proteins 1 and 2 are both surface exposed and generate bactericidal antibodies capable of killing homologous and heterologous strains.
    Ala'Aldeen DA; Borriello SP
    Vaccine; 1996 Jan; 14(1):49-53. PubMed ID: 8821649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of immune responses by purified outer membrane protein complexes from Neisseria meningitidis.
    Marzoa J; Sánchez S; Costoya L; Diéguez-Casal E; Freixeiro P; Brookes C; Allen L; Taylor S; Gorringe AR; Ferreirós CM; Criado MT
    Vaccine; 2012 Mar; 30(13):2387-95. PubMed ID: 21911024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neisseria meningitidis antigen NMB0088: sequence variability, protein topology and vaccine potential.
    Sardiñas G; Yero D; Climent Y; Caballero E; Cobas K; Niebla O
    J Med Microbiol; 2009 Feb; 58(Pt 2):196-208. PubMed ID: 19141737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine.
    Marjuki H; Topaz N; Joseph SJ; Gernert KM; Kersh EN; ; Wang X
    mBio; 2019 Sep; 10(5):. PubMed ID: 31506309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.